Asarina Pharma ApS
CVR 38495712 · Private limited company (ApS) · Dissolved after voluntary liquidation
Asarina Pharma ApS is a Private limited company (ApS), founded on , based in Charlottenlund. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is no longer active (status: dissolved after voluntary liquidation). 8 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2024) shows equity of DKK -107k and a net result of DKK -1.3m.
Company details
- CVR number
- 38495712
- Status
- Dissolved after voluntary liquidation
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- c/o Jakob Dynnes Hansen, Prinsesse Alexandrines Alle 12, 3. tv
2920 Charlottenlund - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 50k
- Employees
- 3 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 3 of 8 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -6.7% |
| Current ratio | 81% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 23 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2024 | 2023 |
|---|---|---|
| Gross profit | DKK -365k | DKK -884k |
| Net profit | DKK -1.3m | DKK -42.9m |
| Equity | DKK -107k | DKK 1.2m |
| Total assets | DKK 1.6m | DKK 2.5m |
| Cash | DKK 1.2m | – |
| Short-term debt | DKK 1.7m | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2024 – 31 Dec 2024 | 167 | ||
| 1 Jan 2023 – 31 Dec 2023 | 199 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 195 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 132 | ||
| 1 Jan 2020 – 31 Dec 2020 | 118 | ||
| 1 Jan 2019 – 31 Dec 2019 | 185 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 155 | ||
| 16 Mar 2017 – 31 Dec 2017 | 152 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Ola Gösta Flink | ||
| Board | Miroslav Reljanovic | ||
| Board | Claude Thierry Laugel | ||
| Board | Erik Graham Fagg | ||
| Board | Sten Gunnar Otto Skolling | ||
| Board | Jakob Dynnes Hansen | ||
| Board | Peter Hviid Nordkild | ||
| Board | Paul Karl Mikael de Potocki | ||
| Owner (100%) | Asarina Pharma AB | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | Asarina Pharma AB |
Address history (2 moves)
| c/o Jakob Dynnes Hansen, Prinsesse Alexandrines Alle 12, 3. tv, 2920 Charlottenlund | |
| c/o Peter Nordkild, Rigensgade 11A, 2., 1316 København K | |
| c/o COBIS, Ole Maaløes Vej 3, 2200 København N |
Former names
| Asarina Pharma ApS | – |
| Asarina Danmark ApS | – |
Employees per year
Other companies at the same address
- ANQOR ApS Bankrupt
- CAPERNOW PROJECTS A/S Bankrupt
- CHBR Holding ApS Bankrupt
- CUB HOLDING ApS Bankrupt
- ESBC HOLDING ApS Bankrupt
- STCH Holding ApS Bankrupt
- STEEN ENGHOLM HOLDING ApS Bankrupt
- STEN Holding ApS Bankrupt
- Selskabet af 7. april 2021 A/S Bankrupt
- Aesculus Bio ApS Active
- Balser Holding ApS Active
- Balser Invest ApS Active
- Balser Venture ApS Active
- COMPASS HUMAN RESOURCES GROUP A/S Active
- Clara Bødtcher-Hansen Holding ApS Active
- Climate & Energy Research Institute ApS Active
- DEFENSIN THERAPEUTICS ApS Active
- Kraka Economics ApS Active
- Next Alliance Group ApS Active
- PN INVESTMENT ApS Active
- People & Performance ApS Active
- RIGENSGADE 11 A/S Opløst
- Sterna Capital Partners Fondsmæglerselskab A/S Active
Similar companies in Gentofte
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Asarina Pharma ApS
Has Asarina Pharma ApS gone bankrupt?
No, Asarina Pharma ApS is not registered as bankrupt in the CVR register. Its status is: dissolved after voluntary liquidation.
Who is the auditor of Asarina Pharma ApS?
Asarina Pharma ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Asarina Pharma ApS founded?
Asarina Pharma ApS was founded on 16 March 2017.
What is the equity of Asarina Pharma ApS?
Equity was DKK -107k according to the annual report for the period ending 31 December 2024.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.